Tuesday, May 8, 2007

can you say PHASE III ? holla!

Aastrom Biosciences Inc. (ASTM) said the Food and Drug Administration cleared it to begin a 120-patient Phase III clinical trial to treat osteonecrosis, also known as avascular necrosis, of the femoral head. Osteonecrosis is a progressive disease that often leads to a total hip replacement.

Extended Hours:
Last 1.56
Change +0.12 (+8.33%)

we added this oddball a few weeks back....

TAKE SOME PROFITS as usual ....we love those 5 and 10% gains!

No comments: